Nucleotide metabolizing ecto-enzymes in Walker 256 tumor cells: Molecular identification, kinetic characterization and biochemical properties

Life Sciences

Volumn 80, Issue 10, 2007, Pages 950-958

  Buffon, Andréia ^a   Ribeiro, Vanessa B ^a   Wink, Márcia R ^b   Casali, Emerson A ^a   Sarkis, João J F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Fundação Faculdade Federal de Ciências Médicas de Porto Alegre   (Brazil)

Author keywords

5 nucleotidase; Adenine nucleotides; Cancer; NTPDases; Walker 256 tumor cells

Indexed keywords

5' NUCLEOTIDASE; ADENINE NUCLEOSIDE; ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ALKALINE PHOSPHATASE; CALCIUM; DIVALENT CATION; ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; ENZYME; GADOLINIUM CHLORIDE; MAGNESIUM; MESSENGER RNA; PHOSPHATE; PROTEIN; SODIUM AZIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); GENETIC IDENTIFICATION; HYDROLYSIS; KINETICS; MALE; NONHUMAN; PH; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; WALKER CARCINOMA;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; CARCINOMA 256, WALKER; CATIONS, DIVALENT; HYDROGEN-ION CONCENTRATION; KINETICS; L-LACTATE DEHYDROGENASE; MALE; NUCLEOTIDES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33846677010     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.11.024     Document Type: Article

References (59)

1. Agteresch H.J., Dagnelie P.C., van den Berg J.W., and Wilson J.H. Adenosine triphosphate: established and potential clinical applications. Drugs 58 2 (1999) 211-232
2. Agteresch H.J., Rietveld T., Kerkhofs L.G., van den Berg J.W., Wilson J.H., and Dagnelie P.C. Beneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: a randomized clinical trial. Journal of Clinical Oncology 20 2 (2002) 371-378
3. Barcz E., Sommer E., Janik P., Marianowski L., and Skopinska-Rozewska E. Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. Oncology Reports 7 6 (2000) 1285-1291
4. Beyer E.C., and Steinberg T.H. Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. Journal of Biological Chemistry 266 13 (1991) 7971-7974
5. Biederbick A., Kosan C., Kunz J., and Elsasser H.P. First apyrase splice variants have different enzymatic properties. Journal of Biological Chemistry 275 25 (2000) 19018-19024
6. Bigonnesse F., Lévesque S.A., Kukulski F., Lecka J., Robson S.C., Fernandes M.J.G., and Sévigny J. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43 18 (2004) 5511-5519
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
8. Bruno A.N., Bonan C.D., Woffchuk S.T., Sarkis J.J.F., and Battastini A.M.O. ATP diphosphohydrolase (NTPDase 1) in rat hippocampal slices and effect of glutamate on the enzyme activity in different phass of development. Life Sciences 71 2 (2002) 215-225
9. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clinical Medicine 2 1 (2002) 45-53
10. Canbolat O., Durak I., Cetin R., Kavutcu M., Demirci S., and Ozturk S. Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Research and Treatment 37 2 (1996) 189-199
11. Casali E.A., Silva T.R., Gelain D.P., Kaiser G.R., Battastini A.M.O., Sarkis J.J., and Bernard E.A. Ectonucleotidase activities in Sertoli cells from immature rats. Brazilian Journal of Medical and Biological Research 34 10 (2001) 1247-1256
12. Cavenagh J.D., Cahill M.R., and Kelsey S.M. Adhesion molecules in clinical medicine. Critical Reviews in Clinical Laboratory Sciences 35 5 (1998) 415-459
13. + 2-stimulated ATPase activity. Analytical Biochemistry 157 (1986) 375-380
14. Clark C.M., and Goodlad G.A. Protein and enzyme content of plasma membranes derived from Walker 256 carcinoma cells grown as ascitic or solid tumours. Cancer Letters 68 2-3 (1993) 91-94
15. Chevillard C., Cárdenas Mc., and Cornish-Bowden A. The competition plot: a simple test of whether two reactions occur at the same active site. Biochemical Journal 289 (1993) 599-604
16. Escalada A., Navarro P., Ros E., Aleu J., Solsona C., and Martin-Satué M. Gadolinium inhibition of ecto-nucleoside triphosphate diphosphohydrolase activity in Torpedo electric organ. Neurochemical Research 29 9 (2004) 1711-1714
17. Fenoglio C., Necchi D., Civallero M., Ceroni M., and Nano R. Cytochemical demonstration of nitric oxide syntase and 5′-nucleotidase in human glioblastoma. Anticancer Research 17 4A (1997) 2507-2511
18. Furstenau C.R., Trentin D.S., Barreto-Chaves M.L., and Sarkis J.J. Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 17 2 (2006) 84-91
19. Gao L., Dong L., and Whitlock Jr. J.P. A novel response to dioxin. Induction of ecto-ATPase gene expression. Journal of Biological Chemistry 273 25 (1998) 15358-15365
20. Guaitani A., Recchia M., Carli M., Rocchtti M., Bartosek I., and Garattini S. Walker carcinoma 256: a model for studies on tumor induced anorexia and cachexia. Oncology 39 3 (1982) 173-178
21. He Y.C., Wang Y.H., Cao J., Chen J.W., Pan D.Y., and Zhou Y.K. Effect of complex amino acid imbalance on growth of tumor in tumor-bearing rats. World Journal of Gastroenterology 9 12 (2003) 2772-2775
22. Hoskin D.W., Reynolds T., and Blay J. Adenosine as a possible inhibitor of killer T-cell activation in the microenvironment of solid tumors. International Journal of Cancer 59 6 (1994) 854-855
23. Ikeda Y., Hayashi I., Kamoshita E., Yamazaki A., Endo H., Ishihara K., Yamashina S., Tsutsumi Y., Matsubara H., and Majima M. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Research 64 15 (2004) 5178-5185
24. Kaczmarek E., Koziak K., Sévigny J., Siegel J.B., Anrather J., Beaudoin A.R., Bach F.H., and Robson S.C. Identification and characterization of CD39 vascular ATP diphosphohydrolase. Journal of Biological Chemistry 271 51 (1996) 33116-33122
25. Kittel A., Garrido M., and Varga G. Localization of NTPDase1/CD39 in normal and transformed human pancreas. Journal of Histochemistry and Cytochemistry 50 4 (2002) 549-556
26. Kegel B., Braun N., Heine P., Maliszewski C.R., and Zimmermann H. An ecto-ATPase and an ecto-ATPdiphosphohydrolase are expressed in rat brain. Neuropharmacology 36 9 (1997) 1189-1200
27. Knowles A.F., and Chiang W.C. Enzymatic and transcriptional regulation of human ecto-ATPase/E-NTPDase 2. Archives of Biochemistry and Biophysics 418 2 (2003) 217-227
28. Knowles A.F., and Nagy A.K. Inhibition of an ecto-ATP-diphosphohydrolase by azide. European Journal of Biochemistry 262 2 (1999) 349-357
29. Knowles A.F., Nagy A.K., Strobel R.S., and Wu-Weis M. Purification, characterization, cloning, and expression of the chicken liver ecto-ATP-diphosphohydrolase. European Journal of Biochemistry 269 9 (2002) 2373-2382
30. Kukulski F., Lévesque S.A., Lavoie É.G., Lecka J., Bigonnesse F., Knowles A.F., Robson S.C., Kirley T.L., and Sévigny J. Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signalling 1 (2005) 193-204
31. Leal D.B., Streher C.A., Neu T.N., Bittencourt F.P., Leal C.A., Silva J.E., Morsch V.M., and Schetinger M.R. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochimica et Biophysica Acta 1721 1-3 (2005) 9-15
32. Mateo J., Harden T.K., and Boyer J.L. Functional expression of a cDNA encoding a human ecto-ATPase. British Journal of Pharmacology 128 2 (1999) 396-402
33. Mujoomdar M., Hoskin D., and Blay J. Adenosine stimulation of the proliferation of colorectal carcinoma cell lines. Roles of cell density and adenosine metabolism. Biochemical Pharmacology 66 9 (2003) 1737-1747
34. Mulero J.J., Yeung G., Nelken S.T., and Ford J.E. CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates. Journal of Biological Chemistry 274 29 (1999) 20064-20067
35. Oses J.P., Cardoso C.M., Germano R.A., Kirst I.B., Rucker B., Furstenau C.R., Wink M.R., Bonan C.D., Battastini A.M.O., and Sarkis J.J.F. Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sciences 74 26 (2004) 3275-3284
36. Paez J.G., Recio J.A., Rouzaut A., and Notario V. Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene. International Journal of Oncology 19 6 (2001) 1249-1254
37. Piffar P.M., Fernandez R., Tchaikovski O., Hirabara S.M., Folador A., Pinto G.J., Jakobi S., Gobbo-Bordon D., Rohn T.V., Fabricio V.E., Moretto K.D., Tosta E., Curi R., and Fernandes L.C. Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats. Cancer Letters 201 2 (2003) 139-148
38. Pilla C., Emanuelli T., Frasseto S.S., Battastini A.M.O., Dias R.D., and Sarkis J.J.F. ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5.) in human blood platelets. Platelets 7 (1996) 225-230
39. Plesner L. Ecto-ATPases: identities and functions. International Review of Cytology 158 (1995) 141-214
40. Rathbone M.P., Middlemis P.J., Kim J.W., DeForge S.P., Smith R.W., and Hugues D.W. Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells. Neuroscience Research 13 1 (1992) 1-17
41. Rettori O., Vieira-Matos A.N., and Tahin Q.S. Variability and discontinuity of the pathognomonic systemic effects caused by the Walker 256 tumor progression in rats. Tumori 81 5 (1995) 370-377
42. Saphner T., Tormcy D.C., and Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. Journal of Clinical Oncology 9 2 (1991) 2294-2886
43. Sevigny J., Sundberg C., Braun N., Guckelberger O., Csizmadia E., Qawi I., Imai M., Zimmermann H., and Robson S.C. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99 8 (2002) 2801-2809
44. Shi J.D., Kukar T., and Wang C.Y. Molecular cloning and characterization of a novel mammalian endo-apyrase (LALP1). Journal of Biological Chemistry 276 20 (2001) 17474-17478
45. Skladchikova G., Ronn L.C., Berezin V., and Bock E. Extracellular adenosine triphosphate affects neural cell adhesion molecule (NCAM)-mediated cell adhesion and neurite outgrowth. Journal of Neuroscience Research 57 2 (1999) 207-218
46. Smith T.M., and Kirley T.L. Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases. Biochimica et Biophysica Acta 1386 1 (1998) 65-78
47. Spychala J. Tumor-promoting functions of adenosine. Pharmacology and Therapeutics 87 2-3 (2000) 161-173
48. Spychala J., Lazarowski E., Ostapkowicz A., Ayscue L.H., Jin A., and Mitchell B.S. Role of estrogen in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer. Clinical Cancer Research 10 2 (2004) 708-717
49. Stewart H.L., Snell K.C., Dunham L.J., and Schlyen S.M. Atlas of Tumor Pathology, Section XII. Air Force Institute of Pathology, Washington, DC (1959) 216-271
50. Stracke M.L., Clair T., and Liotta L.A. Autotaxin, tumor motility-stimulating exophosphodiesterase. Advances in Enzyme Regulation 37 (1997) 135-144
51. Vannoni D., Bernini A., Carlucci F., Civitelli S., Di Pietro M.C., Leoncini R., Rosi F., Tabucchi A., Tanzini G., and Marinello E. Enzyme activities controlling adenosine levels in normal and neoplastic tissues. Medical Oncology 21 2 (2004) 187-195
52. Vollmayer P., Koch M., Braun N., Heine P., Servos J., Israr E., Kegel B., and Zimmermann H. Multiple ecto-nucleotidase in PC12 cells: identification and cellular distribution after heterologous expression. Journal of Neurochemistry 78 5 (2001) 1019-1028
53. Wen L.T., and Knowles A.F. Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor. British Journal of Pharmacology 140 6 (2003) 1009-1018
54. Wink M.R., Tamajusuku A.S.K., Braganhol E., Casali E.A., Barreto-Chaves M.L.M., Sarkis J.J.F., and Battastini A.M.O. Thyroid hormone upregulates ecto-5′-nucleotidase/CD73 in C6 rat glioma cells. Molecular and Cellular Endocrinology 205 1-2 (2003) 107-114
55. Wink M.R., Lenz G., Braganhol E., Tamajusuku A.S., Schwartsmann G., Sarkis J.J.F., and Battastini A.M.O. Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Letters 198 2 (2003) 211-218
56. Woodhouse E.C., Amanatullah D.F., Schetz J.A., Liotta L.A., Stracke M.L., and Clair T. Adenosine receptor mediates motility in human melanoma cells. Biochemical and Biophysical Research Communications 246 3 (1998) 888-894
57. Yeung G., Mulero J.J., McGowan D.W., Bajwa S.S., and Ford J.E. CD39L2, a gene encoding a human nucleoside diphosphatase, predominantly expressed in the heart. Biochemistry 39 42 (2000) 12916-12923
58. Zimmermann H. 5′-nucleotidase: molecular structure and functional aspects. The Biochemical Journal 285 Pt2 (1992) 345-365
59. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Development Research 52 (2001) 44-56